Drug Type Small molecule drug |
Synonyms Compound 11i(The Second Military Medical University) |
Target |
Action inhibitors |
Mechanism HDAC6 inhibitors(Histone deacetylase 6 inhibitors), JAK2 inhibitors(Tyrosine-protein kinase JAK2 inhibitors), Epigenetic drug |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Psoriasis | Preclinical | China | 16 Oct 2024 |